longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

NRC Health

NRC

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
Share your thoughts

What's on your mind?

0 / 2,000
  • G
    GingerJan 13 at 08:17 PM

    $Oklo(OKLO.US)OKLO has secured orders and a site approved by the U.S. Department of Energy (DOE). The market is currently focused on the approval progress by the U.S. Nuclear Regulatory Commission (NRC) and whether the preliminary construction work (groundbreaking) can be completed smoothly within the year. If the approval proceeds smoothly, the company expects to generate its first revenue next year.

    From a long-term investment perspective, the current stock price already holds value for positioning; however, from a technical analysis standpoint, there is a probability of a short-term pullback to around $88. Investors looking to enter may consider staged positioning in this area (SP88 entry).